PT-141 vs Viagra: Comparing the Indexed Record
Researchers comparing PT-141 and Viagra are usually resolving one question: which compound the published record actually supports for the model in front of them.
Compound profiles
PT-141 in the indexed record
Searching PT-141 against the PubMed index returns 21 records, a limited evidence base, alongside 4 registered studies on ClinicalTrials.gov.
Publications carrying this compound include Curr Opin Investig Drugs, Int J Mol Sci, J Sex Med, spanning 2004–2026.
- Bremelanotide — , 2006. PMID: 31369224
- PT-141 Palatin — Curr Opin Investig Drugs, 2004. PMID: 15134289
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives — Int J Mol Sci, 2026. PMID: 42123471
- An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist — J Sex Med, 2006. PMID: 16839319
Viagra in the indexed record
Viagra returns 1,256 indexed records on PubMed, a substantial record, alongside 536 registered studies on ClinicalTrials.gov.
Journals represented in the current index include Arch Ophthalmol, BJU Int, Ear Nose Throat J, spanning 1998–2024.
- Sildenafil (Viagra) and ophthalmology — Surv Ophthalmol, 1999. PMID: 10541153
- [Viagra] — Harefuah, 1998. PMID: 10909529
- Sildenafil (Viagra) and ophthalmology — Arch Ophthalmol, 1999. PMID: 10206581
- Does Viagra really prevent Alzheimer’s disease? — BJU Int, 2024. PMID: 38504448
Classification and why it matters
PT-141 and Viagra sit in different structural classes, and that classification is what determines whether a published protocol for one has any bearing on the other. Peptide research compounds are grouped by sequence length, origin and the receptor families the literature associates with them — not by the outcome a reader might be looking for.
Reading across classes is the most common error in a literature review. A protocol developed for PT-141 describes conditions validated for PT-141: concentration ranges, solvent choice, incubation windows and control selection were all established against that compound. Applying those same conditions to Viagra without re-validation produces data that cannot be compared back to the source publication.
Where the two compounds are studied in overlapping models, the published work almost always treats them as separate arms rather than as substitutes. That separation is the useful signal: it indicates the research record does not consider them equivalent.
Side-by-side research profile
| Parameter | PT-141 | Viagra |
|---|---|---|
| PubMed indexed records | 21 | 1,256 |
| Registered studies (ClinicalTrials.gov) | 4 | 536 |
| Literature depth | Emerging | Extensive |
| Handling class | Lyophilised powder | Lyophilised powder |
| Designation | Research use only | Research use only |
How the literature differs
The indexed record is not symmetrical between these two compounds. Viagra carries 1,235 more indexed records than PT-141, which means published methodology, characterisation data and replication attempts are more readily located for Viagra. For a researcher planning a literature review, that asymmetry usually determines which compound has established reference protocols and which requires primary-source work.
Registered study counts (4 vs 536) track a different signal — formal study registration rather than published output — and the two figures frequently diverge.
What the paperwork has to show
A certificate of analysis is only meaningful when it names the lot printed on the vial. Purity by HPLC and identity by mass spectrometry answer two different questions, and a document reporting one is not evidence of the other.
Physical handling notes
Both arrive lyophilised. Standard practice keeps the unopened vial at -20°C, protected from light, and defers reconstitution until the point of use. Solution-phase stability is the limiting factor in most protocols, not powder-phase stability.
Repeated freezing and thawing is the most common avoidable source of degradation.
Frequently asked questions
How should these compounds be stored?
Lyophilised material is conventionally stored at -20°C protected from light. Reconstituted solution is far less stable and is held at 2-8°C for short-duration laboratory work only.
Which of PT-141 or Viagra has more published research?
Viagra, with 1,256 indexed PubMed records against 21.
Are PT-141 and Viagra the same compound?
No. They are structurally distinct research compounds with separate literature records — 21 indexed records for PT-141 and 1,256 for Viagra.
What is the regulatory status of these compounds?
Neither is an approved drug. Both are supplied strictly for in-vitro laboratory research and are not intended for human or veterinary consumption.
Related references
Research use only. The compounds discussed are supplied for in-vitro laboratory research. They are not drugs, are not approved for the diagnosis, treatment, cure or prevention of any condition, and are not intended for human or veterinary consumption.